CRMP2 Hyperphosphorylation is Characteristic of Alzheimer's Disease and not a Feature Common to Other Neurodegenerative Diseases

MLA

David M. A. Mann, et al. “CRMP2 Hyperphosphorylation Is Characteristic of Alzheimer’s Disease and Not a Feature Common to Other Neurodegenerative Diseases.” Journal of Alzheimer’s Disease, vol. 27, Nov. 2011, pp. 615–25. EBSCOhost, https://doi.org/10.3233/jad-2011-110617.

APA

David M. A. Mann, John E. Mayer, Adam R. Cole, Bettina Platt, Lidy van Aalten, Lynn Bedford, Alessia Usardi, Florian Plattner, Ritchie Williamson, David R. Howlett, & Calum Sutherland. (2011). CRMP2 Hyperphosphorylation is Characteristic of Alzheimer’s Disease and not a Feature Common to Other Neurodegenerative Diseases. Journal of Alzheimer’s Disease, 27, 615–625. https://doi.org/10.3233/jad-2011-110617

Chicago

David M. A. Mann, John E. Mayer, Adam R. Cole, Bettina Platt, Lidy van Aalten, Lynn Bedford, Alessia Usardi, et al. 2011. “CRMP2 Hyperphosphorylation Is Characteristic of Alzheimer’s Disease and Not a Feature Common to Other Neurodegenerative Diseases.” Journal of Alzheimer’s Disease 27 (November): 615–25. doi:10.3233/jad-2011-110617.